Suicidal risk in bipolar I disorder patients and adherence to long‐term lithium treatment

Ana González‐Pinto; Fernando Mosquera; Marta Alonso; Purificación López‐Mahía; Fernando Ramírez; Eduard Vieta; Ross J. Baldessarini

doi:10.1111/j.1399-5618.2006.00368.x

Abstract

1 min read

The findings support growing evidence of lower risk of suicidal acts during closely monitored and highly adherent, long-term treatment with lithium and indicate that treatment adherence is a potentially modifiable factor contributing to antisuicidal benefits.

Related publications

Article2010

Lithium: Still a Cornerstone in the Long-Term Treatment in Bipolar Disorder?

Alessandra Nivoli, Andréa Murru, Eduard Vieta

Article2011

Treatment non-adherence amongst schizoaffective bipolar patients: An unsolved question

Andréa Murru, Caterina del Mar Bonnín, Alessandra Nivoli, Isabella Pacchiarotti, Eduard Vieta, Francesc Colom

Article2006

Evolving trends in the long-term treatment of bipolar disorder

Eduard Vieta, Adriane Ribeiro Rosa

Article2017

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters

Leonardo Tondo, Marc Abramowicz, Martin Alda, Michael Bauer, Alberto Bocchetta, L Bolzani, Cynthia Calkin, Caterina Chillotti, Diego Hidalgo‐Mazzei, Mirko Manchia, B. Müller‐Oerlinghausen, Andréa Murru, Giulio Perugi, Marco Pinna, Giuseppe Quaranta, Daniela Reginaldi, Andreas Reif, Philipp Ritter, Janusz Rybakowski, David Saiger, Gabriele Sani, Valerio Selle, Thomas Stamm, Gustavo Vázquez,

Article2017

Increased hippocampal, thalamus and amygdala volume in long‐term lithium‐treated bipolar I disorder patients compared with unmedicated patients and healthy subjects

Carlos López‐Jaramillo, Cristian Vargas, Ana M. Díaz‐Zuluaga, Juan David Palacio, Gabriel Castrillón, Carrie E. Bearden, Eduard Vieta